Humana Inc. (NYSE:HUM) was downgraded by analysts at BidaskClub from a “buy” rating to a “hold” rating in a report issued on Wednesday, July 19th.
A number of other research analysts also recently issued reports on HUM. UBS AG reiterated a “neutral” rating and issued a $237.00 price target (up previously from $205.00) on shares of Humana in a research note on Wednesday, June 28th. Zacks Investment Research downgraded shares of Humana from a “buy” rating to a “hold” rating in a research note on Tuesday, July 18th. Cowen and Company reiterated a “buy” rating and issued a $230.00 price target on shares of Humana in a research note on Friday, July 14th. Piper Jaffray Companies restated a “buy” rating and set a $246.00 price objective on shares of Humana in a research report on Friday, July 14th. Finally, Oppenheimer Holdings, Inc. initiated coverage on shares of Humana in a research report on Thursday, March 30th. They set an “outperform” rating and a $236.00 price objective for the company. One equities research analyst has rated the stock with a sell rating, nine have issued a hold rating and twelve have assigned a buy rating to the stock. The company has an average rating of “Buy” and an average price target of $236.00.
Shares of Humana (NYSE:HUM) traded up 0.21% during midday trading on Wednesday, hitting $233.08. 1,590,958 shares of the company traded hands. Humana has a 52 week low of $163.50 and a 52 week high of $243.74. The stock has a market capitalization of $33.64 billion, a P/E ratio of 23.75 and a beta of 0.91. The company has a 50-day moving average price of $236.07 and a 200-day moving average price of $220.02.
Humana (NYSE:HUM) last issued its quarterly earnings results on Wednesday, May 3rd. The insurance provider reported $2.75 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.55 by $0.20. Humana had a net margin of 2.71% and a return on equity of 14.38%. The company had revenue of $13.76 billion during the quarter, compared to the consensus estimate of $13.61 billion. During the same quarter in the previous year, the firm earned $1.86 earnings per share. Analysts anticipate that Humana will post $11.15 earnings per share for the current fiscal year.
COPYRIGHT VIOLATION WARNING: “Humana Inc. (HUM) Lowered to Hold at BidaskClub” was originally reported by StockNewsTimes and is the sole property of of StockNewsTimes. If you are accessing this piece on another publication, it was copied illegally and republished in violation of U.S. & international trademark & copyright legislation. The original version of this piece can be read at https://stocknewstimes.com/2017/07/29/humana-inc-hum-downgraded-by-bidaskclub-to-hold-updated.html.
In other news, VP Heidi S. Margulis sold 1,500 shares of the stock in a transaction that occurred on Friday, May 26th. The stock was sold at an average price of $231.96, for a total transaction of $347,940.00. Following the completion of the transaction, the vice president now directly owns 8,150 shares in the company, valued at approximately $1,890,474. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, SVP Brian P. Leclaire sold 4,971 shares of the firm’s stock in a transaction on Wednesday, June 28th. The stock was sold at an average price of $240.00, for a total value of $1,193,040.00. Following the transaction, the senior vice president now owns 14,258 shares in the company, valued at $3,421,920. The disclosure for this sale can be found here. In the last three months, insiders have sold 143,241 shares of company stock valued at $32,446,903. Corporate insiders own 0.80% of the company’s stock.
A number of institutional investors have recently made changes to their positions in HUM. Daiwa Securities Group Inc. raised its stake in shares of Humana by 4.7% in the second quarter. Daiwa Securities Group Inc. now owns 4,450 shares of the insurance provider’s stock valued at $1,071,000 after buying an additional 200 shares in the last quarter. CAPROCK Group Inc. bought a new stake in shares of Humana during the second quarter valued at $213,000. Tokio Marine Asset Management Co. Ltd. raised its stake in shares of Humana by 20.2% in the second quarter. Tokio Marine Asset Management Co. Ltd. now owns 8,703 shares of the insurance provider’s stock valued at $2,094,000 after buying an additional 1,464 shares in the last quarter. Rothschild Asset Management Inc. raised its stake in shares of Humana by 27.4% in the second quarter. Rothschild Asset Management Inc. now owns 5,112 shares of the insurance provider’s stock valued at $1,230,000 after buying an additional 1,100 shares in the last quarter. Finally, Eagle Global Advisors LLC acquired a new position in shares of Humana during the second quarter worth approximately $211,000. Hedge funds and other institutional investors own 99.08% of the company’s stock.
About Humana
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Receive News & Ratings for Humana Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc. and related companies with MarketBeat.com's FREE daily email newsletter.
